$SHWZ
Medicine Man Technologies, Inc. Stock $shwz

$shwz Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000168316822005557 Filed on August 11, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$43.19M	$44.26M	$31.78M
YoY Change	35.67%	44.05%	64.31%
Cost Of Revenue	$17.23M	$19.11M	$20.84M
YoY Change	2.66%	20.73%	72.42%
Gross Profit	$25.96M	$25.16M	$10.94M
YoY Change	72.45%	68.81%	50.8%
Gross Profit Margin	60.12%	56.83%	34.42%
Selling, General & Admin	$6.726M	$6.666M	$15.73M
YoY Change	-40.05%	38.95%	80.0%
% of Gross Profit	25.9%	26.5%	143.8%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$798.4K	$364.4K	$2.541M
YoY Change	-73.14%	-87.92%	41.9%
% of Gross Profit	3.07%	1.45%	23.23%
Operating Expenses	$14.85M	$16.12M	$15.73M
YoY Change	32.36%	54.1%	80.0%
Operating Profit	$11.11M	$9.036M	-$4.791M
YoY Change	189.68%	103.46%	222.62%
Interest Expense	-$3.712M	$29.21M	-$20.73M
YoY Change	146.58%	18435.08%	936.18%
% of Operating Profit	-33.4%	323.29%
Other Income/Expense, Net	-$3.712M	$29.21M	$10.00
YoY Change		18435.32%
Pretax Income	$7.403M	$38.25M	-$25.52M
YoY Change	224.46%	731.72%	699.24%
Income Tax	$5.594M	$4.406M	$1.260M
% Of Pretax Income	75.56%	11.52%
Net Earnings	$1.809M	$33.84M	-$26.78M
YoY Change	86.76%	674.39%	633.76%
Net Earnings / Revenue	4.19%	76.45%	-84.27%
Basic Earnings Per Share	$0.00	$0.65	-$0.61
Diluted Earnings Per Share	$0.00	$0.24	-$571.7K
COMMON SHARES
Basic Shares Outstanding	54.45M shares	49.18M shares	46.84M
Diluted Shares Outstanding	138.0M	133.5M shares	46.84M

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$39.18M	$33.86M	$47.69M
YoY Change	85.07%	60.25%	107.64%
Cash & Equivalents	$38.73M	$33.86M	$47.69M
Short-Term Investments	$451.2K
Other Short-Term Assets	$5.901M	$9.207M	$3.008M
YoY Change	128.81%	393.65%	379.78%
Inventory	$21.29M	$19.38M	$16.38M
Prepaid Expenses
Receivables	$5.176M	$5.754M	$4.197M
Other Receivables	$47.78K	$71.67K	$107.5K
Total Short-Term Assets	$71.59M	$66.81M	$71.38M
YoY Change	88.61%	88.04%	125.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$25.59M	$20.96M	$30.32M
YoY Change	105.86%	182.77%	313.61%
Goodwill	$99.59M	$108.0M	$118.7M
YoY Change
Intangibles	$111.1M
YoY Change
Long-Term Investments		$479.7K	$485.0K
YoY Change		-3.67%	-1.3%
Other Assets	$1.458M	$1.464M	-$3.815M
YoY Change	225.32%	249.05%	-1000.29%
Total Long-Term Assets	$258.0M	$251.3M	$246.6M
YoY Change	64.56%	70.02%	65.04%
TOTAL ASSETS
Total Short-Term Assets	$71.59M	$66.81M	$71.38M
Total Long-Term Assets	$258.0M	$251.3M	$246.6M
Total Assets	$329.6M	$318.1M	$318.0M
YoY Change	69.25%	73.51%	75.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.757M	$3.223M	$3.207M
YoY Change	453.21%	35.67%	27.11%
Accrued Expenses	$9.332M	$8.967M	$1.011M
YoY Change	50.09%	97.41%	-27.95%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$134.5K
YoY Change	-100.0%
Long-Term Debt Due	$1.500M
YoY Change
Total Short-Term Liabilities	$30.04M	$28.56M	$70.28M
YoY Change	115.44%	118.14%	435.56%
LONG-TERM LIABILITIES
Long-Term Debt	$122.9M	$121.1M	$117.9M
YoY Change	107.42%	123.19%	117.26%
Other Long-Term Liabilities	$17.76M	$11.53M	$14.08M
YoY Change	366.55%	182.77%	224.33%
Total Long-Term Liabilities	$140.7M	$132.6M	$131.9M
YoY Change	123.07%	127.36%	125.19%
TOTAL LIABILITIES
Total Short-Term Liabilities	$30.04M	$28.56M	$70.28M
Total Long-Term Liabilities	$140.7M	$132.6M	$131.9M
Total Liabilities	$170.7M	$161.2M	$202.2M
YoY Change	121.69%	125.67%	181.99%
SHAREHOLDERS EQUITY
Retained Earnings	-$18.90M	-$20.71M
YoY Change
Common Stock	$56.07K	$56.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.991M	$1.991M
YoY Change
Treasury Stock Shares
Shareholders Equity	$158.9M	$157.0M	$115.8M
YoY Change
Total Liabilities & Shareholders Equity	$329.6M	$318.1M	$318.0M
YoY Change	69.25%	73.51%	75.68%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	$1.809M	$33.84M	-$26.78M
YoY Change	86.76%	674.39%	633.76%
Depreciation, Depletion And Amortization	$798.4K	$364.4K	$2.541M
YoY Change	-73.14%	-87.92%	41.9%
Cash From Operating Activities	$4.005M	-$13.79M	$5.831M
YoY Change	17.14%	4450.66%	243.3%
INVESTING ACTIVITIES
Capital Expenditures	-$5.504M	-$4.400M	-$2.608M
YoY Change	106.42%	633.71%	311.87%
Acquisitions
YoY Change
Other Investing Activities	$3.297M	-$5.586M	-$90.32M
YoY Change	-156.41%	498.86%	39.02%
Cash From Investing Activities	-$2.207M	-$9.986M	-$92.92M
YoY Change	-74.07%	551.63%	41.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.065M	9.953M	28.38M
YoY Change	-40.26%		-66.86%
NET CHANGE
Cash From Operating Activities	4.005M	-13.79M	5.831M
Cash From Investing Activities	-2.207M	-9.986M	-92.92M
Cash From Financing Activities	3.065M	9.953M	28.38M
Net Change In Cash	4.863M	-13.83M	-58.71M
YoY Change	12686.64%	653.22%	-370.2%
FREE CASH FLOW
Cash From Operating Activities	$4.005M	-$13.79M	$5.831M
Capital Expenditures	-$5.504M	-$4.400M	-$2.608M
Free Cash Flow	$9.509M	-$9.393M	$8.439M
YoY Change	56.26%	-3267.54%	261.92%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	MDCL	Segment Assets SegmentAssets	318147981	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	19375341	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	11121997	usd
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	71667	usd
CY2021Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	0	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001622879
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	MDCL	Return Of Common Stock As Compensation To Employees Officers Andor Directors ReturnOfCommonStockAsCompensationToEmployeesOfficersAndorDirectors		usd
	us-gaap	Dividends Dividends		usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
	us-gaap	Dividends Dividends		usd
	MDCL	Conversion Of Preferred Stock To Common Stock ConversionOfPreferredStockToCommonStock		usd
CY2021Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions		usd
CY2021Q2	MDCL	Return Of Common Stock As Compensation To Employees Officers Andor Directors ReturnOfCommonStockAsCompensationToEmployeesOfficersAndorDirectors		usd
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2021Q2	MDCL	Conversion Of Preferred Stock To Common Stock ConversionOfPreferredStockToCommonStock		usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2022Q2	us-gaap	Dividends Dividends		usd
CY2022Q2	MDCL	Conversion Of Preferred Stock To Common Stock ConversionOfPreferredStockToCommonStock		usd
CY2022Q2	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue		usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt		usd
	MDCL	Common Stock Issued In Connection With Acquisitions CommonStockIssuedInConnectionWithAcquisitions		usd
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Entity File Number EntityFileNumber	000-55450
	dei	Entity Registrant Name EntityRegistrantName	MEDICINE MAN TECHNOLOGIES, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-5289499
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4880 Havana Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 201
	dei	Entity Address City Or Town EntityAddressCityOrTown	Denver
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80239
	dei	City Area Code CityAreaCode	(303)
	dei	Local Phone Number LocalPhoneNumber	371-0387
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	54446575	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33862423	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	106400216	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5753621	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3866828	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7743112	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2523214	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2548885	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	121080876	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	66806164	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	123912255	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3212679	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1988973	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20955604	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10253226	usd
CY2022Q2	us-gaap	Goodwill Goodwill	107969018	usd
CY2021Q4	us-gaap	Goodwill Goodwill	43316267	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11930443	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7652750	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	105427462	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	97582330	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	13813	usd
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	216771	usd
CY2022Q2	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	479741	usd
CY2021Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	493553	usd
CY2022Q2	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	0	usd
CY2021Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	143333	usd
CY2022Q2	us-gaap	Nontrade Receivables Noncurrent NontradeReceivablesNoncurrent	290648	usd
CY2021Q4	us-gaap	Nontrade Receivables Noncurrent NontradeReceivablesNoncurrent	303086	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1464163	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	514962	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14755181	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8511780	usd
CY2022Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	251341817	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	161118537	usd
CY2022Q2	us-gaap	Assets Assets	318147981	usd
CY2021Q4	us-gaap	Assets Assets	285030792	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3222956	usd
CY2022Q2	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	73387	usd
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	36820	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8966821	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5592222	usd
CY2022Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	11634721	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	34923013	usd
CY2022Q2	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	0	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	134498	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3795776	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	usd
CY2022Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	863971	usd
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2027741	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	28557632	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	45263179	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	97482468	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	11532286	usd
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4797495	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8715480	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	132613162	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	106197948	usd
CY2022Q2	us-gaap	Liabilities Liabilities	161170794	usd
CY2021Q4	us-gaap	Liabilities Liabilities	151461127	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	55995681	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54446575	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	45484314	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	44745870	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	55996	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	45485	usd
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	86994	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	82566	shares
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	87	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	87	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	179623469	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	162815097	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-20711687	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27773968	usd
CY2022Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	886459	shares
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	517044	shares
CY2022Q2	us-gaap	Treasury Stock Value TreasuryStockValue	1990678	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1517036	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	156977187	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	133569665	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	318147981	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	285030792	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	44263392	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	30728841	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	76040946	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	50068955	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	19106944	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	15826341	usd
	us-gaap	Cost Of Revenue CostOfRevenue	39946995	usd
	us-gaap	Cost Of Revenue CostOfRevenue	27913451	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	25156448	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	14902500	usd
	us-gaap	Gross Profit GrossProfit	36093951	usd
	us-gaap	Gross Profit GrossProfit	22155504	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6666044	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13521755	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7987134	usd
CY2022Q2	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	1516544	usd
CY2021Q2	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	1519016	usd
	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	4101016	usd
	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	3714124	usd
CY2022Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	7240368	usd
CY2021Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2992055	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	12537145	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	4861413	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	697842	usd
CY2021Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1153018	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1688925	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2636824	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	16120798	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	10461584	usd
	us-gaap	Operating Expenses OperatingExpenses	31848841	usd
	us-gaap	Operating Expenses OperatingExpenses	19199495	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	9035650	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	4440916	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	4245110	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	2956009	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-7489205	usd
CY2021Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1713770	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-14791459	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2675053	usd
CY2022Q2	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	36705764	usd
CY2021Q2	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	1864741	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	23288292	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	610927	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2022Q2	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	0	usd
CY2021Q2	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	0	usd
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	0	usd
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	292479	usd
CY2022Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	-5264	usd
CY2021Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	6627	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-13813	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	221257	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	29211295	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	157598	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	8483027	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1550390	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4405962	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	228474	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53886727	shares
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	33840983	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5665856	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	685088	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	33840983	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	4370040	usd
	us-gaap	Net Income Loss NetIncomeLoss	7062281	usd
	us-gaap	Net Income Loss NetIncomeLoss	720531	usd
CY2022Q2	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1766575	usd
CY2021Q2	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	-0	usd
	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	3510019	usd
	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	-0	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	32074408	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4370040	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3552262	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	720531	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.65
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49178494	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42332144	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49178494	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42286168	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	133481667	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53975521	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	133481667	shares
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4370040	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	7062281	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	720531	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	41774859	usd
	us-gaap	Net Income Loss NetIncomeLoss	720531	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	20240000	usd
	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	680861	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	50449206	usd
	MDCL	Conversion Of Preferred Stock To Common Stock ConversionOfPreferredStockToCommonStock	-3800914	usd
	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	184536	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2059671	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	111939679	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	133569665	usd
	us-gaap	Net Income Loss NetIncomeLoss	7062281	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	15100450	usd
	MDCL	Return Of Common Stock As Compensation To Employees Officers Andor Directors ReturnOfCommonStockAsCompensationToEmployeesOfficersAndorDirectors	243625	usd
	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	697891	usd
	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	473642	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2636824	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	776917	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	156977187	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	109304698	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	4370040	usd
CY2021Q2	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	236055	usd
CY2021Q2	us-gaap	Dividends Dividends	2920446	usd
CY2021Q2	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	71340	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1020670	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	111939679	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	115782552	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	33840983	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	7099944	usd
CY2022Q2	MDCL	Return Of Common Stock As Compensation To Employees Officers Andor Directors ReturnOfCommonStockAsCompensationToEmployeesOfficersAndorDirectors	243625	usd
CY2022Q2	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	697891	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	-687808	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	156977187	usd
	us-gaap	Net Income Loss NetIncomeLoss	7062281	usd
	us-gaap	Net Income Loss NetIncomeLoss	720531	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5501399	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4807147	usd
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	23288292	usd
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	610927	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-13813	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	221257	usd
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-0	usd
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	292479	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1474380	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1677476	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1854067	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3903984	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3368807	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1458786	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1250938	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	946701	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	367593	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	369181	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	77444	usd
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	2248013	usd
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	1169538	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-50000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1163770	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7961974	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1395416	usd
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	95903316	usd
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	66082072	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7004445	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1203180	usd
	MDCL	Issuance Of Notes Receivables IssuanceOfNotesReceivables	0	usd
	MDCL	Issuance Of Notes Receivables IssuanceOfNotesReceivables	181911	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2825	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	29580	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-102910586	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-67132921	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	19165362	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	40348241	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	4433042	usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	0	usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-5000000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	14736363	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	50282798	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	38334767	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	85631039	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-72537793	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	19893534	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	106400216	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1237235	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33862423	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21130769	usd
	us-gaap	Interest Paid Net InterestPaidNet	9004575	usd
	us-gaap	Interest Paid Net InterestPaidNet	2131495	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	6840000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	MDCL	Common Stock Issued In Connection With Acquisitions CommonStockIssuedInConnectionWithAcquisitions	9900506	usd
	MDCL	Issuance Of Common Stock IssuanceOfCommonStock	379146	usd
	MDCL	Issuance Of Common Stock IssuanceOfCommonStock	0	usd
	MDCL	Return Of Common Stock ReturnOfCommonStock	551875	usd
	MDCL	Return Of Common Stock ReturnOfCommonStock	0	usd
CY2021Q4	MDCL	Purchase Price PurchasePrice	93100000	usd
CY2022Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	33862423	usd
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	106400216	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zsOlVziyyBR9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_865_z6HZNGvTt5Ac">Use of Estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported therein. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may be based upon amounts that differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84D_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zLJzzehnhSc2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86B_zSdoBw9jbN5i">Reclassifications</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain prior period amounts have been reclassified to conform to the current period presentation. These reclassifications had no impact on the Company’s net earnings and financial position.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	135046	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	135046	usd
CY2022Q2	us-gaap	Accounts Receivable Gross AccountsReceivableGross	6044269	usd
CY2021Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	4169914	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	9207275	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3038176	usd
CY2022Q2	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	3296343	usd
CY2021Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	2585705	usd
CY2022Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	509015	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1232589	usd
CY2021Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	196903	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	308593	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1688925	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2636824	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	24168283	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12242199	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3212679	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1988973	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20955604	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10253226	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	821757	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1223706	usd
CY2021Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	260843	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	455480	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	117357905	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11930443	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	105235080	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7652750	usd
CY2022Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	2138846	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	4277693	usd
CY2021Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	2755736	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	4351667	usd
CY2022Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	0	usd
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	0	usd
CY2021	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues	48936674	usd
CY2021	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-14013661	usd
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	34923013	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-23288292	usd
CY2022Q2	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	11634721	usd
CY2022Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1833844	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3590017	usd
CY2022Q2	us-gaap	Goodwill Goodwill	107969018	usd
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6912280	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5573329	usd
CY2022Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	8505411	usd
CY2022Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	3957650	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	5535992	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	12676	usd
CY2021Q1	us-gaap	Proceeds From Loans ProceedsFromLoans	10000000	usd
CY2021Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	750000	usd
CY2021Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2025-02-26
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	80000000	usd
CY2022Q2	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	5500000	usd
CY2022Q2	us-gaap	Unsecured Debt UnsecuredDebt	1000000	usd
CY2022Q2	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	7446718	usd
CY2021Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	8289743	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	44887772	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	48477789	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	121080876	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	97482468	usd
CY2022Q2	MDCL	Less Current Portion Of Long Term Debt LessCurrentPortionOfLongTermDebt	0	usd
CY2021Q4	MDCL	Less Current Portion Of Long Term Debt LessCurrentPortionOfLongTermDebt	0	usd
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	121080876	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	97482468	usd
	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	173415366.00	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	7446718.00	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	44887772.00	usd
CY2022Q2	MDCL	Long Term Debts LongTermDebts	128527594.00	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14755181	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3795776	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	11532286	usd
CY2022Q2	MDCL	Lessee Operating Lease Liability Payments Due Next Twelve Months1 LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths1	24566696	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	754274	usd
CY2022Q2	MDCL	Present Value Of Lease Liabilities PresentValueOfLeaseLiabilities	23812422	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2436876	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	4230773	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	4153572	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour	3988575	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive	2993623	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive	6763278	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	24566697	usd
CY2022Q2	MDCL	Escrow Shares EscrowShares	4428	shares
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3510019	usd
CY2022Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1766575	usd
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Profit Loss ProfitLoss	38246945	usd
CY2022Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	886459	shares
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	517044	shares
CY2021Q2	us-gaap	Profit Loss ProfitLoss	4598513	usd
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Convertible Shares Issuable PreferredStockConvertibleSharesIssuable	272	shares
	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	245017	shares
CY2022Q2	us-gaap	Revenues Revenues	44263392	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	19106944	usd
CY2022Q2	MDCL	Gross Profit Amount GrossProfitAmount	25156448	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2608282	usd
CY2022Q2	us-gaap	Depreciation Depreciation	364399	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	33840983	usd
CY2022Q2	MDCL	Segment Assets SegmentAssets	318147981	usd
	us-gaap	Revenues Revenues	76040946	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	39946995	usd
	MDCL	Gross Profit Amount GrossProfitAmount	36093951	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4277694	usd
	us-gaap	Depreciation Depreciation	1223706	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	7062281	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4405962	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	228474	usd
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.1152	pure
CY2021Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0497	pure
	us-gaap	Profit Loss ProfitLoss	12728137	usd
	us-gaap	Profit Loss ProfitLoss	1405620	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5665856	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	685088	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.4451	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.4874	pure

Files In Submission

Name	View Source	Status
0001683168-22-005557-index-headers.html	Edgar Link	pending
0001683168-22-005557-index.html	Edgar Link	pending
0001683168-22-005557.txt	Edgar Link	pending
0001683168-22-005557-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
mdcl-20220630.xsd	Edgar Link	pending
medman_ex1001.htm	Edgar Link	pending
medman_ex1002.htm	Edgar Link	pending
medman_ex3101.htm	Edgar Link	pending
medman_ex3102.htm	Edgar Link	pending
medman_ex32.htm	Edgar Link	pending
medman_i10q-063022.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
mdcl-20220630_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
mdcl-20220630_def.xml	Edgar Link	unprocessable
mdcl-20220630_lab.xml	Edgar Link	unprocessable
mdcl-20220630_pre.xml	Edgar Link	unprocessable
medman_i10q-063022_htm.xml	Edgar Link	completed
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SHWZ
Medicine Man Technologies, Inc. Stock $shwz

2022 Q3 Form 10-Q Financial Statement

#000168316822005557 Filed on August 11, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHWZ Medicine Man Technologies, Inc. Stock $shwz

2022 Q3 Form 10-Q Financial Statement

#000168316822005557 Filed on August 11, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHWZ
Medicine Man Technologies, Inc. Stock $shwz